Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 257 blog entries.

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare)

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...]

The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.

By |June 10th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare)

End of antiviral medicine prescribing for 2024/25 influenza season

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2024/25 influenza season appeared first on Community Pharmacy England.

By |May 15th, 2025|Lexpos News|Comments Off on End of antiviral medicine prescribing for 2024/25 influenza season

MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products

MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products Drug alert number: EL(25)A/21 Date issued: 13 May 2025 Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information [...]

The post MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products appeared first on Community Pharmacy England.

By |May 13th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products

Ivermectin 3mg tablets and Paxlovid 150mg/100mg tablets added to the Discount Not Deducted (DND) list from May 2025

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 May 2025. This takes the total [...]

The post Ivermectin 3mg tablets and Paxlovid 150mg/100mg tablets added to the Discount Not Deducted (DND) list from May 2025 appeared first on Community Pharmacy England.

By |April 30th, 2025|Lexpos News|Comments Off on Ivermectin 3mg tablets and Paxlovid 150mg/100mg tablets added to the Discount Not Deducted (DND) list from May 2025

Extended FP34C submission deadline for prescriptions dispensed in April 2025

With Early May Bank Holiday (5 May 2025) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 May 2025, to submit their April FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing [...]

The post Extended FP34C submission deadline for prescriptions dispensed in April 2025 appeared first on Community Pharmacy England.

By |April 30th, 2025|Lexpos News|Comments Off on Extended FP34C submission deadline for prescriptions dispensed in April 2025